Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Handgretinger

Showing results (171-180 of 187) with videos related to

Pageof 19
Sort By:
Bone Marrow Transplantation|March 20, 2012
A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-upK A Kasow, C F Stewart, R C Barfield, et al.
Cytotherapy|October 20, 2006
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BMI Müller, S Kordowich, C Holzwarth, et al.
Bone Marrow Transplantation|May 30, 2003
Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimenG A Hale, L C Bowman, J P Woodard, et al.
Cell Proliferation|January 24, 2008
Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cellsS Kuçi, Z Kuçi, S Schmid, et al.
Bone Marrow Transplantation|September 5, 2007
Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemiaB Meissner, A Borkhardt, D Dilloo, et al.
Bone Marrow Transplantation|April 13, 2004
Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosisP Woodard, K Helton, H McDaniel, et al.
Bone Marrow Transplantation|March 3, 2004
Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effectiveP Bader, H Kreyenberg, W Hoelle, et al.
Cytotherapy|June 19, 2007
Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 29-30 September 2006, Tübingen, GermanyR Schäfer, M Dominici, I Müller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2003
Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcomeG A Hale, R J Rochester, H E Heslop, et al.
Clinical and Experimental Immunology|May 25, 2013
Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responsesN Rieber, C Gille, N Köstlin, et al.
Pageof 19

Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
Bone Marrow Transplantation|March 20, 2012
A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-upK A Kasow, C F Stewart, R C Barfield, et al.
Cytotherapy|October 20, 2006
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BMI Müller, S Kordowich, C Holzwarth, et al.
Bone Marrow Transplantation|May 30, 2003
Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimenG A Hale, L C Bowman, J P Woodard, et al.
Cell Proliferation|January 24, 2008
Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cellsS Kuçi, Z Kuçi, S Schmid, et al.
Bone Marrow Transplantation|September 5, 2007
Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemiaB Meissner, A Borkhardt, D Dilloo, et al.
Bone Marrow Transplantation|April 13, 2004
Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosisP Woodard, K Helton, H McDaniel, et al.
Bone Marrow Transplantation|March 3, 2004
Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effectiveP Bader, H Kreyenberg, W Hoelle, et al.
Cytotherapy|June 19, 2007
Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 29-30 September 2006, Tübingen, GermanyR Schäfer, M Dominici, I Müller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2003
Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcomeG A Hale, R J Rochester, H E Heslop, et al.
Clinical and Experimental Immunology|May 25, 2013
Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responsesN Rieber, C Gille, N Köstlin, et al.
Pageof 19